FDA-Cleared AI Triage Tool Offered Free to Support Radiology Departments
Medical startup Nines provides its FDA-cleared AI triage software at no cost until June 30 to assist overwhelmed radiology departments during the COVID-19 pandemic. The tool automatically identifies potentially critical brain conditions on CT scans to help doctors prioritize urgent cases.
Medical startup Nines offers its FDA-cleared AI triage tool for free to all radiology departments until June 30 to help reduce workloads during the COVID-19 pandemic. The software, called NinesAI, automatically analyzes CT scans to identify potential cases of intracranial hemorrhage and mass effect, alerting doctors to patients who need immediate attention.
By acting as a supplemental early warning system, the technology eliminates time-consuming manual sorting steps and allows radiologists to focus their expertise on final diagnostics and complex special cases. This practical application of machine learning handles the repetitive aspects of image processing, significantly speeding up the review pipeline for medical facilities.
Founded by Google self-driving car pioneer David Stavens, Nines is the first company to secure FDA clearance for an AI tool that triages these specific brain conditions. The free access applies to both existing teleradiology customers and in-house radiology practices, giving healthcare providers a crucial resource without any additional financial burden.